<DOC>
	<DOCNO>NCT01337206</DOCNO>
	<brief_summary>The SX-ELLA Stent Esophageal Degradable BD ( BD Stent ) design dilation benign esophageal lesion , namely : ( 1 ) stenosis ( peptic , anastomotic caustic ) refractory standard therapy , ( 2 ) achalasia refractory standard therapy .</brief_summary>
	<brief_title>SX ELLA Esophageal Degradable BD Stent System</brief_title>
	<detailed_description />
	<criteria>A recurrent benign esophageal stricture due cause ( surgery , radiation therapy , corrosive ingestion , peptic injury , PDT , ablative therapy ) Patient &lt; 18 year old Patient unwilling unable sign date inform consent Patient unwilling unable comply followup schedule Patient pregnant , breastfeeding , plan become pregnant next 12 month Patient simultaneously participate another drug device study patient complete followup phase primary objective previous study le 30 day prior enrollment study Patient life expectancy &lt; 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Esophageal Stenosis</keyword>
	<keyword>Esopageal Strictures</keyword>
	<keyword>Esophageal Dysphagia</keyword>
</DOC>